Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
toujeo solostar 300 unités/ml solution injectable en stylo pré-rempli
sanofi-aventis (suisse) sa - insulinum glarginum - solution injectable en stylo pré-rempli - insulinum glarginum 10.91 mg corresp. insulinum glarginum 300 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum q.s. ad ph, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - diabète sucré - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
lantus solution injectable en cartouche
sanofi-aventis (suisse) sa - insulinum glarginum - solution injectable en cartouche - insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - diabète sucré - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
lantus solostar (stylo prérempli) solution injectable
sanofi-aventis (suisse) sa - insulinum glarginum - solution injectable - insulinum glarginum 3.6378 mg corresp. insulinum glarginum 100 u., zinci chloridum, glycerolum (85 per centum), acidum hydrochloridum concentratum, natrii hydroxidum 0.1 mg, metacresolum, aqua ad iniectabile ad solutionem pro 1 ml. - diabète sucré - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
abasaglar kwikpen 100 u/ml solution injectable
eli lilly (suisse) sa - insulinum glarginum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., glycerolum, zinci oxidum, acidum hydrochloridum dilutum, natrii hydroxidum corresp. natrium 0.04 mg, metacresolum, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
abasaglar cartouche 100 u/ml solution injectable
eli lilly (suisse) sa - insulinum glarginum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., glycerolum, metacresolum, zincum ut zinci oxidum, acidum hydrochloridum dilutum, natrii hydroxidum corresp. natrium 0.04 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
suliqua 100/50 solution injectable
sanofi-aventis (suisse) sa - insulinum glarginum, lixisenatidum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., lixisenatidum 50 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
suliqua 100/33 solution injectable
sanofi-aventis (suisse) sa - insulinum glarginum, lixisenatidum - solution injectable - insulinum glarginum 3.64 mg corresp. insulinum glarginum 100 u., lixisenatidum 33 µg, zinci chloridum, glycerolum (85 per centum), methioninum, conserv.: metacresolum 2.7 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml. - diabète sucré - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
insulinum
boiron sa - insulinum - tropfen / spray, trinkampullen, globuli, tabletten, trituration / pulver - c3, d, d6, d - homöopathisch
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
insulinum ext.
boiron sa - insulinum - d6, d; c3, d - homöopathisch
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
insulinum gg
boiron sa - insulinum - lm/q1, d; k30, d - homöopathisch